CES 2021 Taiwan startup Singular Wings Medical breaks the challenges of OSA diagnosis with AI
News provided by
Share this article
Share this article
TAIPEI, Jan. 12, 2021 /PRNewswire/ Sleep apnea, also known as obstructive sleep apnea (OSA), is a hidden issue in modern society that still awaits an effective cure. Research suggests that 30% of the global population have sleeping disorders. People with the condition face a 6 times higher risk of experiencing a wake-up stroke and an 11-times higher risk of traffic accidents, while bearing higher risks of coronary artery disease, arrhythmia, cerebrovascular disease, and other diseases. Above all, people with OSA increase social healthcare costs and burdens. However, 90% of OSA goes undiagnosed or untreated. In fact, the costs of treating OSA could be as much as $10 billion per year.